Year |
Citation |
Score |
2019 |
Martin GR, Blomquist CM, Henare KL, Jirik FR. Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice. Scientific Reports. 9: 14281. PMID 31582793 DOI: 10.1038/S41598-019-50656-5 |
0.346 |
|
2016 |
Miller KA, Keenan CM, Martin GR, Jirik FR, Sharkey KA, Wieser ME. The expression levels of cellular prion protein affect copper isotopic shifts in the organs of mice Journal of Analytical Atomic Spectrometry. 31: 2015-2022. DOI: 10.1039/C6Ja00195E |
0.516 |
|
2015 |
Martin GR, Sharkey KA, Jirik FR. Orally administered indomethacin acutely reduces cellular prion protein in the small intestine and modestly increases survival of mice exposed to infectious prions. Scandinavian Journal of Gastroenterology. 50: 542-9. PMID 25599123 DOI: 10.3109/00365521.2014.1003400 |
0.569 |
|
2012 |
Martin GR, Alvarez AL, Bashashati M, Keenan CM, Jirik FR, Sharkey KA. Endogenous cellular prion protein regulates contractility of the mouse ileum. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: e412-24. PMID 22762267 DOI: 10.1111/J.1365-2982.2012.01970.X |
0.65 |
|
2011 |
Martin GR, Keenan CM, Sharkey KA, Jirik FR. Endogenous prion protein attenuates experimentally induced colitis. The American Journal of Pathology. 179: 2290-301. PMID 21924230 DOI: 10.1016/J.Ajpath.2011.07.025 |
0.568 |
|
2011 |
Pushie MJ, Pickering IJ, Martin GR, Tsutsui S, Jirik FR, George GN. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics : Integrated Biometal Science. 3: 206-14. PMID 21264406 DOI: 10.1039/C0Mt00037J |
0.334 |
|
2010 |
Martin GR, Keenan CM, Sharkey KA, Jirik F. S1735 Over-Expression of the Endogenous Prion Protein (PrpC) Attenuates Experimentally-Induced Colitis Gastroenterology. 138: S-263. DOI: 10.1016/S0016-5085(10)61205-X |
0.512 |
|
2010 |
Martin GR, Bashashati M, Keenan CM, MacNaughton WK, Jirik F, Sharkey KA. 724 The Functional Role of Cellular Prion Protein in the Enteric Nervous System Gastroenterology. 138: S-97. DOI: 10.1016/S0016-5085(10)60445-3 |
0.586 |
|
2008 |
Martin GR, Perretti M, Flower RJ, Wallace JL. Annexin-1 modulates repair of gastric mucosal injury. American Journal of Physiology. Gastrointestinal and Liver Physiology. 294: G764-9. PMID 18202108 DOI: 10.1152/Ajpgi.00531.2007 |
0.33 |
|
2008 |
Beck PL, Makhija S, Martin GR, Li Y, Urbanski SJ, Medlicott SA. T1294 Severe Immunosuppressant Induced Ileal Crohn's Disease-Like Injury in Solid Organ Transplantation Recipients Treated with Mycophenolate Mofetil (MMF) Gastroenterology. 134: A-525. DOI: 10.1016/S0016-5085(08)62451-8 |
0.339 |
|
2007 |
Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, Tanaka H, Sharkey KA. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology. Gastrointestinal and Liver Physiology. 293: G211-21. PMID 17395898 DOI: 10.1152/Ajpgi.00530.2006 |
0.513 |
|
2006 |
Sigalet DL, Bawazir O, Martin GR, Wallace LE, Zaharko G, Miller A, Zubaidi A. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences. 51: 1557-66. PMID 16927140 DOI: 10.1007/S10620-006-9077-5 |
0.385 |
|
2006 |
Martin GR, Beck PL, Sigalet DL. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology : Wjg. 12: 4117-29. PMID 16830359 DOI: 10.3748/Wjg.V12.I26.4117 |
0.353 |
|
2006 |
Martin GR, Wallace JL. Gastrointestinal inflammation: a central component of mucosal defense and repair. Experimental Biology and Medicine (Maywood, N.J.). 231: 130-7. PMID 16446488 DOI: 10.1177/153537020623100202 |
0.324 |
|
2006 |
Baglole CJ, Sigalet DL, Martin GR, Yao S, Meddings JB. Acute denervation alters the epithelial response to adrenoceptor activation through an increase in alpha1-adrenoceptor expression on villus enterocytes. British Journal of Pharmacology. 147: 101-8. PMID 16258526 DOI: 10.1038/Sj.Bjp.0706424 |
0.333 |
|
2005 |
Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. Journal of Pediatric Surgery. 40: 763-8. PMID 15937810 DOI: 10.1016/J.Jpedsurg.2005.01.038 |
0.304 |
|
2005 |
Attard JA, Raval MJ, Martin GR, Kolb J, Afrouzian M, Buie WD, Sigalet DL. The effects of systemic hypoxia on colon anastomotic healing: an animal model. Diseases of the Colon and Rectum. 48: 1460-70. PMID 15909070 DOI: 10.1007/S10350-005-0047-3 |
0.306 |
|
2005 |
Martin GR, Wallace LE, Hartmann B, Holst JJ, Demchyshyn L, Toney K, Sigalet DL. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology. 288: G431-8. PMID 15388486 DOI: 10.1152/Ajpgi.00242.2004 |
0.346 |
|
2004 |
Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology. 286: G964-72. PMID 14962847 DOI: 10.1152/Ajpgi.00509.2003 |
0.378 |
|
2003 |
Martin GR, Meddings JB, Sigalet DL. 3-0 methylglucose absorption in vivo correlates with nutrient absorption and intestinal surface area in experimental short bowel syndrome. Jpen. Journal of Parenteral and Enteral Nutrition. 27: 65-70. PMID 12549601 DOI: 10.1177/014860710302700165 |
0.322 |
|
2003 |
Martin GR, Wallace LE, Sigalet DL. Nutrient stimulated glucagon-like peptide-2 and crypt cell production in experimental short bowel syndrome Gastroenterology. 124: A596. DOI: 10.1016/S0016-5085(03)83019-6 |
0.333 |
|
2001 |
Topstad D, Martin G, Sigalet D. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection Journal of Pediatric Surgery. 36: 750-754. PMID 11329581 DOI: 10.1053/Jpsu.2001.22952 |
0.316 |
|
2000 |
Sigalet DL, Martin GR, Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. Journal of Pediatric Surgery. 35: 661-4. PMID 10813318 DOI: 10.1053/Jpsu.2000.5937 |
0.308 |
|
1996 |
Yanchar NL, Riegel TM, Martin G, Fedorak RN, Kneteman NM, Sigalet DL. Tacrolimus (FK506)--its effects on intestinal glucose transport. Transplantation. 61: 630-4. PMID 8610392 DOI: 10.1097/00007890-199602270-00019 |
0.309 |
|
Show low-probability matches. |